Correlation of radiological and histopathological response after neoadjuvant radiotherapy in soft tissue sarcoma
- PMID: 36637511
- DOI: 10.1080/0284186X.2023.2166427
Correlation of radiological and histopathological response after neoadjuvant radiotherapy in soft tissue sarcoma
Abstract
Background: The aim of this study was to assess the association between radiological and histopathological response after neoadjuvant radiotherapy (nRT) in soft tissue sarcoma (STS), as well as the prognostic value of the different response evaluation methods on the oncological outcome.
Methods: A retrospective cohort of patients with localized STS of the extremity and trunk wall, treated with nRT followed by resection were included. The radiological response was assessed by RECIST 1.1 (RECIST) and MR-adapted Choi (Choi), histopathologic response was evaluated according to the EORTC-STBSG recommendations. Oncological outcome parameters of interest were local recurrence-free survival (LRFS), disease metastases-free survival (DMFS), and overall survival (OS).
Results: For 107 patients, complete pre- and postoperative pathology and imaging datasets were available. Most tumors were high-grade (77%) and the most common histological subtypes were undifferentiated pleomorphic sarcoma/not otherwise specified (UPS/NOS, 40%), myxoid liposarcoma (MLS, 21%) and myxofibrosarcoma (MFS, 16%). When comparing RECIST to Choi, the response was differently categorized in 58%, with a higher response rate (CR + PR) with Choi. Radiological responders showed a significant lower median percentage of viable cells (RECIST p = .050, Choi p = .015) and necrosis (RECIST p < .001), and a higher median percentage of fibrosis (RECIST p = .005, Choi p = .008), compared to radiological non-responders (SD + PD). RECIST, Choi, fibrosis, and viable cells were not significantly associated with altered oncological outcome, more necrosis was associated with poorer OS (p = .038).
Conclusion: RECIST, Choi and the EORTC-STBSG response score show incongruent results in response evaluation. The radiological response was significantly correlated with a lower percentage of viable cells and necrosis, but a higher percentage of fibrosis. Apart from necrosis, radiological nor other histopathological parameters were associated with oncologic outcomes.
Keywords: Sarcoma; histopathologic response; neoadjuvant radiotherapy; radiological response; response evaluation.
Similar articles
-
Heterogeneity in response to neoadjuvant radiotherapy between soft tissue sarcoma histotypes: associations between radiology and pathology findings.Eur Radiol. 2025 Mar;35(3):1337-1350. doi: 10.1007/s00330-024-11258-6. Epub 2024 Dec 19. Eur Radiol. 2025. PMID: 39699680
-
Impact of histological subtype on radiological and pathological response after neoadjuvant radiotherapy in soft tissue sarcoma.Eur J Surg Oncol. 2021 Dec;47(12):2995-3003. doi: 10.1016/j.ejso.2021.07.008. Epub 2021 Jul 12. Eur J Surg Oncol. 2021. PMID: 34281731
-
Neoadjuvant Radiation in High-Grade Soft-Tissue Sarcomas: Histopathologic Features and Response Evaluation.Am J Surg Pathol. 2022 Aug 1;46(8):1060-1070. doi: 10.1097/PAS.0000000000001922. Epub 2022 Jun 3. Am J Surg Pathol. 2022. PMID: 35687332
-
Imaging response evaluation after neoadjuvant treatment in soft tissue sarcomas: Where do we stand?Crit Rev Oncol Hematol. 2021 Apr;160:103309. doi: 10.1016/j.critrevonc.2021.103309. Epub 2021 Mar 20. Crit Rev Oncol Hematol. 2021. PMID: 33757836 Review.
-
ESR Essentials: assessing the radiological response of liver metastases to systemic therapy-practice recommendations by the European Society of Gastrointestinal and Abdominal Radiology.Eur Radiol. 2025 Apr 4. doi: 10.1007/s00330-025-11540-1. Online ahead of print. Eur Radiol. 2025. PMID: 40185923 Review.
Cited by
-
Paradoxical Response to Neoadjuvant Therapy in Undifferentiated Pleomorphic Sarcoma: Increased Tumor Size on MRI Associated with Favorable Pathology.Cancers (Basel). 2025 Feb 27;17(5):830. doi: 10.3390/cancers17050830. Cancers (Basel). 2025. PMID: 40075678 Free PMC article.
-
What Is the Prognostic Value of the Pathologic Response after Neoadjuvant Radiotherapy in Soft Tissue Sarcoma? An Institutional Study Using the EORTC-STBSG Response Score.Cancers (Basel). 2024 Oct 11;16(20):3449. doi: 10.3390/cancers16203449. Cancers (Basel). 2024. PMID: 39456543 Free PMC article.
-
The impact of CT-based adipose tissue distribution and sarcopenia on treatment outcomes in patients with high-risk soft tissue sarcoma.BMC Cancer. 2025 Apr 11;25(1):671. doi: 10.1186/s12885-025-14050-x. BMC Cancer. 2025. PMID: 40217461 Free PMC article.
-
The Prognostic Relevance of MRI Characteristics in Myxofibrosarcoma Patients Treated with Neoadjuvant Radiotherapy.Cancers (Basel). 2023 May 19;15(10):2843. doi: 10.3390/cancers15102843. Cancers (Basel). 2023. PMID: 37345181 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials